- Home
- INVH vs PODD Comparison
INVH vs PODD Comparison
Compare INVH & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INVH
- PODD
- Stock Information
- Founded
- INVH 2012
- PODD 2000
- Country
- INVH United States
- PODD United States
- Employees
- INVH N/A
- PODD N/A
- Industry
- INVH Real Estate
- PODD Medical/Dental Instruments
- Sector
- INVH Finance
- PODD Health Care
- Exchange
- INVH Nasdaq
- PODD Nasdaq
- Market Cap
- INVH 21.1B
- PODD 21.5B
- IPO Year
- INVH 2017
- PODD 2007
- Fundamental
- Price
- INVH $30.45
- PODD $281.00
- Analyst Decision
- INVH Buy
- PODD Strong Buy
- Analyst Count
- INVH 17
- PODD 19
- Target Price
- INVH $38.15
- PODD $320.11
- AVG Volume (30 Days)
- INVH 3.6M
- PODD 504.7K
- Earning Date
- INVH 07-30-2025
- PODD 08-07-2025
- Dividend Yield
- INVH 3.81%
- PODD N/A
- EPS Growth
- INVH 14.19
- PODD 67.46
- EPS
- INVH 0.89
- PODD 5.55
- Revenue
- INVH $2,647,487,000.00
- PODD $2,198,900,000.00
- Revenue This Year
- INVH $5.39
- PODD $24.54
- Revenue Next Year
- INVH $3.70
- PODD $17.48
- P/E Ratio
- INVH $34.30
- PODD $50.63
- Revenue Growth
- INVH 5.09
- PODD 23.48
- 52 Week Low
- INVH $29.37
- PODD $173.00
- 52 Week High
- INVH $37.80
- PODD $329.33
- Technical
- Relative Strength Index (RSI)
- INVH 33.08
- PODD 38.53
- Support Level
- INVH $29.86
- PODD $282.75
- Resistance Level
- INVH $32.05
- PODD $290.25
- Average True Range (ATR)
- INVH 0.62
- PODD 5.49
- MACD
- INVH -0.16
- PODD 0.05
- Stochastic Oscillator
- INVH 21.14
- PODD 2.88
About INVH Invitation Homes Inc.
Invitation Homes owns a portfolio of over 85,000 single-family rental homes. The company focuses on owning homes in the starter and move-up segments of the housing market with an average sale price around $350,000 and generally less than 1,800 square feet. The portfolio is spread across 16 target markets that feature high employment and household formation growth with almost 70% of the portfolio in the Western U.S. and Florida; 15 of the 16 markets featuring average rents lower than homeownership costs.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetics are using it worldwide.